These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 5983666)
21. Monoamine oxidase inhibitors for depression. Med Lett Drugs Ther; 1980 Jul; 22(14):58-60. PubMed ID: 7382910 [No Abstract] [Full Text] [Related]
22. Medication attitudes and drug response. Lipman RS; Uhlenhuth EH; Rickels K; Covi L Dis Nerv Syst; 1969 Jul; 30(7):453-9. PubMed ID: 4897533 [No Abstract] [Full Text] [Related]
23. [Influence of IMAO on glycemic equilibrium: potentiation of insulinic hypoglycemia by beta-phenyl-ethyl-hydrazine (Nardil)]. Patrignani A; Miele V G Psichiatr Neuropatol; 1968; 96(1):29-43. PubMed ID: 5712513 [No Abstract] [Full Text] [Related]
25. Selective response of twins to an antidepressant drug. Kline NA Dis Nerv Syst; 1968 May; 29(5):333. PubMed ID: 5654380 [No Abstract] [Full Text] [Related]
26. Clinical trial of a new type promptly acting psychoenergetic agent (phenyl-isopropyl-methylpropinyl-HCl, "E-250"). Varga E; Tringer L Acta Med Acad Sci Hung; 1967; 23(3):289-95. PubMed ID: 6056555 [No Abstract] [Full Text] [Related]
27. Treatment-resistant depression: response to low-dose transdermal but not oral selegiline. Morgan PT J Clin Psychopharmacol; 2007 Jun; 27(3):313-4. PubMed ID: 17502787 [No Abstract] [Full Text] [Related]
28. Meprobamate and benactyzine (Deprol) in the treatment of depression in general practice. (A controlled study). Gordon PE Dis Nerv Syst; 1967 Apr; 28(4):234-40. PubMed ID: 5337279 [No Abstract] [Full Text] [Related]
29. A controlled in-patient pilot study with the antidepressant mebanazine, a mono amine oxidase inhibitor of the hydrazine group. I. Keddie KM; Cooper AJ Int J Neuropsychiatry; 1966 Aug; 2(4):346-50. PubMed ID: 5338745 [No Abstract] [Full Text] [Related]
30. Total prolonged drug-induced REM sleep suppression in anxious-depressed patients. Wyatt RJ; Fram DH; Kupfer DJ; Snyder F Arch Gen Psychiatry; 1971 Feb; 24(2):145-55. PubMed ID: 4321956 [No Abstract] [Full Text] [Related]
31. The bearing of treatment of the classification of the affective disorders. Gurney C; Roth M; Kerr TA; Schapira K Br J Psychiatry; 1970 Sep; 117(538):251-5. PubMed ID: 5480682 [No Abstract] [Full Text] [Related]
32. A look at Gerovital--the "youth" drug. Kent S Geriatrics; 1976 Dec; 31(12):95-6, 101-2. PubMed ID: 1001903 [TBL] [Abstract][Full Text] [Related]
33. Biphasic drugs in the treatment of depression with anxiety. Krakowski AJ Psychosomatics; 1969; 10(3):7-11. PubMed ID: 5822699 [No Abstract] [Full Text] [Related]
34. An open trial of MAO inhibitors in bulimia. Stewart JW; Walsh BT; Wright L; Roose SP; Glassman AH J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746 [TBL] [Abstract][Full Text] [Related]
35. [Tolerance of 75-20 C in geriatrics]. Moreau L Sem Ther; 1968 Jan; 44(1):23-5. PubMed ID: 5743961 [No Abstract] [Full Text] [Related]
36. [Semeiology of anxiety]. Petit M Encephale; 1983; 9(4 Suppl 2):199B-204B. PubMed ID: 6676100 [TBL] [Abstract][Full Text] [Related]
37. Differential response patterns to MAO inhibitors and tricyclics. Nies A J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487 [TBL] [Abstract][Full Text] [Related]
38. The effect of augmentation with moclobemide on symptoms of schizophrenia. Silver H; Aharon N; Hausfater N; Jahjah N Int Clin Psychopharmacol; 1999 May; 14(3):193-5. PubMed ID: 10435775 [TBL] [Abstract][Full Text] [Related]
39. [Symptomatology of circular depression and prediction of the efficacy of treatment with tricyclic antidepressants]. Zaĭtsev SG; Prokhorova IS; Mikeshina NG; Gromova VV Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(8):1198-1205. PubMed ID: 6624347 [TBL] [Abstract][Full Text] [Related]